Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSphere Medical Holding Regulatory News (SPHR)

  • There is currently no data for SPHR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appt of Regional Distributor Company Update

21 Jul 2016 07:00

RNS Number : 8024E
Sphere Medical Holding plc
21 July 2016
 

21 July 2016

 

Sphere Medical Holding plc

("Sphere Medical" or the "Company")

Appointment of Regional Distributor and Company Update

 

Italian Distributor Appointed

 

Sphere Medical Holding plc (AIM: SPHR.L), an innovative point-of-care monitoring and diagnostic devices company, is pleased to announce the appointment of Burke & Burke S.p.A. ("Burke & Burke"), as exclusive distributor of Proxima products in Italy. Burke & Burke, established 40 years ago, has considerable experience in point of care devices and already markets a number of medical devices, including complex ventilation devices and anaesthesia monitoring devices, to critical care units in hospitals across Italy, with Proxima adding a complimentary product to its portfolio.

 

Under the terms of the distribution agreement, Burke & Burke will commence marketing of Proxima 4 immediately following its launch. Burke & Burke has already committed to place an initial order for Proxima 4 monitors and consumables.

 

Sphere Medical will continue to pursue the appointment of further regional distributors for Proxima products in other European markets where not yet present.

 

Company Update

 

The Company is continuing with preparations for the commercial launch of Proxima 4 in Europe later this year, and is close to completing the CE-marking process. Ahead of the launch of Proxima 4, the Company continues to build awareness of the patient-related and cost benefits of the Proxima platform: while sales of Proxima 3 in the first half of 2016 continued to be modest, interest has continued to grow, with more hospitals evaluating the product and patient connections growing by more than 50% during the first half of 2016 over the previous six months.

 

An important market trend is that hospitals increasingly wish to capture data from point of care devices such as Proxima in electronic records. Sphere Medical has established connectivity between the Proxima platform and both Conworx and Clinisys data management systems, two of the leading systems in Europe. The Conworx customer base includes 1,800 hospitals in 25 countries. CliniSys software systems are used in over 2,500 laboratories in 35 countries. Moreover, CliniSys products are utilised in 40% of NHS Trusts in England and Scotland, with a further significant presence in Germany, Netherlands, Belgium, France and Spain. The new connectivity will allow the seamless transfer of test results from Proxima directly into laboratory information systems and electronic patient records.

 

The Company's manufacturing facility in Wales, which opened in February 2016, has already commenced production of Proxima components, and over the next 12 to 18 months the Company plans to gradually transfer more elements of the production process from its site at Harston, Cambridge to the Welsh manufacturing facility.

 

Dr. Wolfgang Rencken, Chief Executive Officer of Sphere Medical, said: "We are delighted to appoint Burke and Burke as our first regional distributor of the Proxima platform. This is an excellent endorsement of Proxima and we look forward to the launch of Proxima 4 later this year, in addition to further distribution agreements."

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

 

- Ends -

 

For further information, please contact:

 

Sphere Medical Holding plc

Tel: +44 (0)1223 875 222

Dr Wolfgang Rencken, Chief Executive Officer

Richard Wright, Chief Financial Officer

Panmure Gordon

Tel: +44 (0) 20 7886 2500

Freddy Crossley (Corporate Finance)

Duncan Monteith (Corporate Finance)

Tom Salvesen (Corporate Broking)

Consilium Strategic Communications

Tel: +44 (0) 20 3709 5700

Mary-Jane Elliott

spheremedical@consilium-comms.com

Chris Gardner

Ivar Milligan

Hendrik Thys

 

 

Notes for Editors

 

About Sphere Medical (AIM: SPHR.L)

 

Sphere Medical is an innovative point-of-care medical device company. Its Proxima platform measures blood gases, electrolytes and metabolites at the patient's bedside and aims to improve patient care and reduce health system costs. The device is currently sold directly to the critical care market via Sphere Medical's sales force in the UK, Germany, The Netherlands and Belgium. For further information, please visit www.spheremedical.com.

 

 

About Burke & Burke

 

Burke & Burke, based in the Milan area, was founded in 1976 and is focused on Critical Care, Perinatal Care, Point of Care Testing and Anaesthesia & Monitoring. It has sales teams operating throughout Italy and is a distributor for more than a dozen medical device companies.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCAKKDBKBKBFOB
Date   Source Headline
18th Jul 201311:17 amRNSTR-1: Notification of Major Interest in Shares
17th Jul 20135:20 pmRNSTR-1: Notification of Major Interest in Shares
17th Jul 20134:36 pmRNSTR-1: Notification of Major Interest in Shares
17th Jul 20133:14 pmRNSTR-1: Notification of Major Interest in Shares
17th Jul 20138:01 amRNSDirector/PDMR Shareholding
16th Jul 201312:00 pmRNSResult of General Meeting
16th Jul 20137:00 amRNSResult of Open Offer
8th Jul 20137:00 amRNSPositive results from Proxima technology
1st Jul 20137:00 amRNSPosting of Shareholder Circular
28th Jun 20134:08 pmRNS2012 Annual Report & Accounts and Notice of AGM
28th Jun 20131:13 pmRNSFinal Results for the year ended 31 December 2012
28th Jun 20131:04 pmRNSProposed Collaboration Agreement and Fundraising
4th Dec 20122:40 pmRNSTR-1: Notification of Major Interest in Shares
23rd Nov 20127:00 amRNSPositive Results from Pelorus 1500 Study
25th Sep 20129:30 amRNSPresenting at Proactive Investors Investor Forum
20th Sep 20127:00 amRNSInterim Results 2012
29th Aug 20127:00 amRNSNotice of Interim Results
16th Jul 20127:00 amRNSPelorus 1500 IVD Achieves CE Marking
10th Jul 20127:00 amRNSFirst Sales Order from Sorin for CPB Product
21st Jun 20127:00 amRNSSphere Appoints Distributor in Japan
29th May 20122:29 pmRNSResult of Annual General Meeting
21st May 20127:00 amRNSGrant of Options and Directors' Interests
21st May 20127:00 amRNSGrant of Share Options and Directors' Interests
8th May 20127:00 amRNS2011 Annual Report & Accounts and Notice of AGM
22nd Mar 20127:00 amRNSPreliminary Results
24th Feb 20127:00 amRNSNotice of Preliminary Results
8th Feb 20127:00 amRNSImproving Accuracy of Propofol Dosing
5th Jan 20121:13 pmRNSAmended Notice of Interest in Shares
19th Dec 20117:00 amRNSProxima Generation 2 Achieves European CE Marking
13th Dec 20113:51 pmRNSNotification of Major Interest in Shares
23rd Nov 20117:00 amRNSScope Extension to include Manufacturing
22nd Nov 20113:10 pmRNSNotice of Interest in Shares
21st Nov 201112:49 pmRNSNotice of Interest in Shares
21st Nov 20117:00 amRNSNotification of Major Interest in Shares
21st Nov 20117:00 amRNSClinical Trial Success
18th Nov 20118:40 amRNSCompleted Second Admission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.